Watch now to see how RELISTOR targets mu-opioid receptors
Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?
Any other details or context?
The targeted action of RELISTOR inhibits opioids from binding to mu-receptors in tissues such as the gastrointestinal (GI) tract, decreasing their constipating effects.1
To report SUSPECTED ADVERSE REACTIONS, contact Salix at 1-800-508-0024 or FDA at 1-800-FDA-1088 or www.fda.gov/Safety/MedWatch/
Please click here for full Prescribing Information for RELISTOR tablets and RELISTOR injection.